Evidence map›Paper›PMID 42069627›Full record

ArticleBreast cancer research : BCR2026

Multi‑scale immune and spatial profiling of sclerosing adenosis and surrounding breast tissue identifies an immune‑cold field phenotype associated with breast cancer risk.

Nicole Cruz-Reyes, Hongling Liang, Melody Stallings-Mann, Laura Pacheco-Spann, Bryan M McCauley, Yuanhang Liu, Robert A Vierkant, Jessica L Fischer, Denice L Gehling, Lisa R Seymour and 4 more

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nicole Cruz-Reyes *Department of Cancer Biology, Mayo Clinic College of Medicine, Jacksonville, FL, USA.ORCID http://orcid.org/0000-0002-7511-6169
Hongling Liang *Department of Cancer Biology, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Melody Stallings-MannDepartment of Cancer Biology, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Laura Pacheco-SpannDepartment of Quantitative Health Sciences, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Bryan M McCauleyDepartment of Quantitative Health Sciences, Mayo Clinic College of Medicine, MN, Rochester, USA.
Yuanhang LiuDepartment of Quantitative Health Sciences, Mayo Clinic College of Medicine, MN, Rochester, USA.
Robert A VierkantDepartment of Quantitative Health Sciences, Mayo Clinic College of Medicine, MN, Rochester, USA.
Jessica L FischerDepartment of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.
Denice L GehlingDepartment of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.
Lisa R SeymourDepartment of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.
Amy C DegnimDepartment of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.
Mark E ShermanDepartment of Quantitative Health Sciences, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Stacey J WinhamDepartment of Quantitative Health Sciences, Mayo Clinic College of Medicine, MN, Rochester, USA.
Derek C RadiskyDepartment of Cancer Biology, Mayo Clinic College of Medicine, Jacksonville, FL, USA. radisky.derek@mayo.edu.ORCID http://orcid.org/0000-0002-1962-8784

Funding

NCI NIH HHS CA229811
6 · The paper itself

Abstract

backgroundBenign breast disease (BBD) is common and confers heterogeneous increases in breast cancer risk; however, risk prediction relies mainly on histopathology and clinical factors. Sclerosing adenosis (SA) is a proliferative BBD lesion associated with an approximately two-fold increase in risk, yet most women with SA never develop breast cancer. We hypothesize that the immune-stromal microenvironment of SA and its surrounding lobular field relates to subsequent invasive breast cancer.

methodsIn a nested case-control study within a BBD cohort, we profiled 24 sclerosing adenosis (SA) biopsies (9 developing invasive breast cancer within 15 years, cases; 15 cancer-free at ≥ 15 years, controls). We integrated whole-tissue NanoString gene-expression profiling with multiplex immunofluorescence (MxIF) imaging of SA lesions and surrounding morphologically normal lobules. We measured immune and stromal biomarkers in SA lesions and adjacent lobules, with image analysis masked to case-control status, integrated these data with whole-tissue gene expression, and summarized both microenvironment patterns and the proximity of immune cells to proliferating epithelium.

resultsSA biopsies from women who later developed cancer showed a low-immune, high-stromal gene-expression program, whereas controls were enriched for immune signatures. Stromal densities of CD8⁺, CD68⁺ and RUNX3⁺ cells in both lobular stroma and SA lesions mirrored this axis and were markedly lower in cases than controls. Unsupervised clustering identified immune-cold and immune-hot lobule types and four SA lesion field archetypes; immune-hot lobules and immune-hot/epithelium-proliferative lesion fields were enriched in controls. Spatial analyses further showed that immune-hot lobules have stromal immune cells positioned closer to proliferating epithelium and enriched CD27-CD8 microclusters, whereas SA lesions from cases exhibit greater immune-to-Ki67 distances, fewer boundary-proximal CD8⁺ sentinels, and depletion of CD27-RUNX3 and RUNX3-CD8 microclusters.

conclusionsThese findings support an association of an immune-cold SA lesion embedded within an immune-cold lobular field phenotype with subsequent invasive breast cancer risk in women with SA, and suggest that spatially organized, RUNX3-rich immune microenvironments may contribute to epithelial surveillance. Validation in larger cohorts will be needed to confirm generalizability and clarify lesion-specific versus field-wide contributions.

Indexed as

BreastBreast NeoplasmsFibrocystic Breast DiseaseAdultAgedBiomarkers, TumorCase-Control StudiesFemaleGene Expression ProfilingHumansMiddle AgedPhenotypeTumor MicroenvironmentBiomarkers, TumorBenign breast diseaseBreast cancer riskImmune microenvironmentMultiplex immunofluorescenceNanoStringSclerosing adenosisSpatial analysisTumour microenvironment

Identifiers

PMID42069627
PMCPMC13285291

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.